Page 4 - Mark Foundation News Today

Chimeric Antigen Receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-treat cancers, as they have the ability to deliver targeted therapies that can kill tumor cells.

Longtime NYU Langone Health researcher Alec Kimmelman is taking over as director of the Laura and Isaac Perlmutter Cancer Center, more than two weeks after the previous director was terminated following social media posts he made related to the Israel-Hamas war.  The former director, Jewish cancer biologist Benjamin Neel, was fired after he made public...

/PRNewswire/ -- The Mark Foundation for Cancer Research announced 16 outstanding projects in its latest class of ASPIRE awards, granting more than $5 million...

A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University.

Cyprus International Distribution Systems Limited, owner of the largest Ukrainian producer of mineral waters IDS Ukraine, has become subject to Ukrainian sanctions: blocking assets, preventing the withdrawal of capital abroad and a ban on increasing the charter capital of related Ukrainian companies.

A University of Tennessee Health Science Center (UTHSC) researcher is a member of a prestigious team that has just received a highly competitive Endeavor Award totaling $3 million from The Mark Foundation for Cancer Research.

/PRNewswire/ -- The Mark Foundation for Cancer Research announced the recipients of its 2023 Endeavor Award program, providing a total of $12M across seven...

/PRNewswire/ -- The Mark Foundation for Cancer Research today announced an alliance with Takeda to accelerate the discovery and development of novel treatments...

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines ...